Serum Parathyroid Hormone in Relation to All-Cause and Cardiovascular Mortality: The Hoorn Study
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
CONTEXT: Higher PTH concentrations have been associated with fatal cardiovascular diseases (CVDs), but data in the general population are scarce. OBJECTIVE: We investigated whether higher PTH concentrations are prospectively associated with all-cause and CVD mortality. DESIGN, SETTING, PARTICIPANTS: This study used data from the Hoorn Study, a prospective population-based cohort with baseline measurements between 2000 and 2001. We included 633 participants, mean age 70.1 ± 6.6 years, 51% female. Serum intact PTH was measured using a 2-site immunoassay. MAIN OUTCOME MEASURES: Outcomes were all-cause and CVD mortality based on clinical files and coded according to the International Classification of Diseases, ninth revision. We used Kaplan-Meier plots to estimate survival curves and Cox regression to estimate hazard ratios (HRs) using season-specific PTH quartiles. RESULTS: During a median follow-up of 7.8 years, 112 participants died, of which 26 deaths (23%) were cardiovascular. Survival curves by PTH quartiles differed for all-cause mortality (log-rank P = .054) and CVD mortality (log-rank P = .022). In a multivariate model, the highest PTH quartile was associated with all-cause mortality; HR = 1.98 (1.08, 3.64). Kidney function slightly attenuated the PTH risk association, but risk persisted; HR = 1.93 (1.04, 3.58). The results for CVD mortality showed a similar pattern, although the association was significant only in a threshold model (quartile 4 vs quartile 1-3); HR = 2.56 (1.11, 5.94). CONCLUSIONS: Among a general older population, higher PTH concentrations were associated with higher all-cause mortality risk, mostly explained by fatal CVD events. We suggest to evaluate whether individuals with high PTH concentrations benefit from therapeutic approaches targeted to decrease PTH concentrations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Unwin, N. C. (2006) · Cited by 1,661
Fraser, W. D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60507-9 · Cited by 934
Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure
Rostand, S. G., & Drüeke, T. B. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00575.x · Cited by 419
Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the Community
Hagström, E., Hellman, P., Larsson, T. E., Ingelsson, E., Berglund, L., Sundström, J., Melhus, H., Held, C., Lind, L., Michaëlsson, K., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.808733 · Cited by 416
The Dutch EPIC food frequency questionnaire. II. Relative validity and reproducibility for nutrients
Ocke, M. (1997) · International Journal of Epidemiology · doi:10.1093/ije/26.suppl_1.s49 · Cited by 375
Jablonski, K. L., Chonchol, M., Pierce, G. L., Walker, A. E., & Seals, D. R. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.160929 · Cited by 361
Prevalence and Determinants of Glucose Intolerance in a Dutch Caucasian Population: The Hoorn Study
Mooy, J. M., Grootenhuis, P. A., Vries, H. D., Valkenburg, H. A., Bouter, L. M., Kostense, P. J., & Heine, R. J. (1995) · Diabetes Care · doi:10.2337/diacare.18.9.1270 · Cited by 323
Primary hyperparathyroidism and heart disease ? a review
ANDERSSON, P., RYDBERG, E., & WILLENHEIMER, R. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.07.010 · Cited by 303
Cited by
Tomaschitz, A., Ritz, E., Pieske, B., Rus-Machan, J., Kienreich, K., Verheyen, N., Gaksch, M., Grübler, M., Fahrleitner-Pammer, A., Mrak, P., et al. (2014) · Metabolism · doi:10.1016/j.metabol.2013.08.016 · Cited by 166
“[36] van Ballegooijen AJ, Reinders I, Visser M, et al.”
BackgroundSelf-citationPihlstrøm, H. K., Dahle, D. O., Mjøen, G., Pilz, S., März, W., Abedini, S., Holme, I., Fellström, B., Jardine, A. G., & Holdaas, H. (2015) · Transplantation · doi:10.1097/tp.0000000000000583 · Cited by 150
“risk of death.(21,44) A similar risk pattern was seen in the study on RTR by Bleskestad et al.”
ResultSelf-citationThe renin–angiotensin–aldosterone system and calcium-regulatory hormones
Vaidya, A., Brown, J. M., & Williams, J. S. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2014.125 · Cited by 93
Brown, J. M., Williams, J. S., Luther, J. M., Garg, R., Garza, A. E., Pojoga, L. H., Ruan, D. T., Williams, G. H., Adler, G. K., & Vaidya, A. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.01910 · Cited by 88
Association between Parathyroid Hormone Levels and Inflammatory Markers among US Adults
Cheng, S., Liu, C., Liu, T., Hsu, Y., & Lee, J.-J. (2014) · Mediators of Inflammation · doi:10.1155/2014/709024 · Cited by 94
Purde, M.-T., Nock, S., Risch, L., Escobar, P. M., Grebhardt, C., Nydegger, U. E., Stanga, Z. G., & Risch, M. (2015) · Translational research · doi:10.1016/j.trsl.2015.11.001 · Cited by 75
Brown, J., de Boer, I. H., Robinson-Cohen, C., Siscovick, D. S., Kestenbaum, B., Allison, M., & Vaidya, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3949 · Cited by 71
Is Normocalcemic Primary Hyperparathyroidism Harmful or Harmless?
Chen, G., Xue, Y., Zhang, Q., Xue, T., Yao, J., Huang, H., Liang, J., Li, L., Lin, W., Lin, L., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4432 · Cited by 66
“The increased serum calcium induce vascular contraction and raise BP (12).”
BackgroundThe role of vitamin D deficiency in cardiovascular disease: where do we stand in 2013?
Pilz, S., Gaksch, M., O’Hartaigh, B. W. J., Tomaschitz, A., & März, W. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1152-z · Cited by 68
Self-citationBarreto, F. C., Stinghen, A. E. M., de Oliveira, R. B., Franco, A. T. B., Moreno, A. N., Barreto, D. V., Pecoits‐Filho, R., Drüeke, T. B., & Massy, Z. A. (2014) · Brazilian Journal of Nephrology · doi:10.5935/0101-2800.20140033 · Cited by 69
Peng, C., Zhang, Z., Liu, J., Chen, H., Tu, X., Hu, R., Ni, J., Weng, N., Pang, H., & Xue, Z. (2016) · Head & Neck · doi:10.1002/hed.24657 · Cited by 48
Meems, L. M. G., Brouwers, F. P. J., Joosten, M. M., Heerspink, H. J. L., de Zeeuw, D., Bakker, S. J. L., Gansevoort, R. T., van Gilst, W. H., van der Harst, P., & de Boer, R. A. (2016) · ESC Heart Failure · doi:10.1002/ehf2.12089 · Cited by 45
Serum Inflammation-based Scores in Endocrine Tumors
Marques, P., de Vries, F., Dekkers, O. M., Korbonits, M., Biermasz, N. R., & Pereira, A. M. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab238 · Cited by 44
Interactions between adrenal-regulatory and calcium-regulatory hormones in human health
Brown, J. M., & Vaidya, A. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000062 · Cited by 39
Hilali, J. E., de Koning, E. J., van Ballegooijen, A. J., Lips, P. T. A. M., Sohl, E., van Marwijk, H., Visser, M., & van Schoor, N. M. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.12.001 · Cited by 36
“BMI (kg/m(2)) 27 [24,29] 27 [24,30] 27 [24,30] 26 [2 Physical activity (min/day) 41 [17,79] 21 [4,48] 34 [13,62] 52 [2 Number of chronic diseases 1 [0,2] 1 [1,2] 1 [0,2] 1 [0,2 eGFR 63 [54,71] 62 [51,70] 62 [52,70] 63 [5”
Self-citationParathyroid hormone, cardiovascular and all-cause mortality: A meta-analysis
Yang, B. Y., Lu, C., Wu, Q., Zhang, J., Zhao, H., & Cao, Y.-K. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.01.034 · Cited by 35
Hypertension, Antihypertensive Medications, and Risk of Incident Primary Hyperparathyroidism
Vaidya, A., Curhan, G. C., Paik, J. M., Kronenberg, H. M., & Taylor, E. N. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1619 · Cited by 29
Salmi, I. A., Bieber, B. A., Rukhaimi, M. A., AlSahow, A., Shaheen, F. A. M., Al-Ghamdi, S. M. G., Wakeel, J. A., Ali, F. A., Al-Aradi, A., Alhejaili, F. F., et al. (2020) · Kidney360 · doi:10.34067/kid.0000772020 · Cited by 29
Isakov, O., Ghinea, R., Beckerman, P., Mor, E., Riella, L. V., & Hod, T. (2020) · Clinical Transplantation · doi:10.1111/ctr.14085 · Cited by 26
Parathyroid Gland Function in Primary Aldosteronism
Bekeran, M., Reincke, M., & Asbach, E. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565224 · Cited by 25
High serum parathyroid hormone and calcium are risk factors for hypertension in Japanese patients
Yagi, S., Aihara, K., Kondo, T., Endo, I., Hotchi, J., Ise, T., Iwase, T., Akaike, M., Matsumoto, T., & Sata, M. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej14-0004 · Cited by 22
Langen, J., Kayacelebi, A. A., Beckmann, B., Weigt-Usinger, K., Carmann, C., Hörster, I., Lilienthal, E., Richter-Unruh, A., Tsikas, D., & Lücke, T. (2015) · Amino Acids · doi:10.1007/s00726-015-2028-8 · Cited by 19
“Among a general older population, higher PTH concentrations are associated with higher all-cause mortality risk, mostly explained by fatal cardiovascular disease events (van Ballegooijen et al. 2013).”
BackgroundZhang, X., Tu, W., Manson, J. E., Tinker, L. F., Liu, S., Cauley, J. A., Qi, L., Mouton, C. P., Martin, L. W., Hou, L., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011021 · Cited by 15
“Our findings are less consistent with the Hoorn Study, a Netherlands population-based study of white men and women in which high PTH levels were significantly associated with CVD mortality, but not independent of 25(OH) D levels.(17) In contrast, PTH did not predict CVD mortality in a population of middle-aged and old…”
ResultChen, W. R., Chen, Y. D., Shi, Y., Yin, D. W., Wang, H., & Sha, Y. (2014) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000094 · Cited by 19
Toraman, A. (2019) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2019.96 · Cited by 15
Palmeri, N. O., Davidson, K. W., Whang, W., Kronish, I. M., Edmondson, D. E., & Walker, M. D. (2017) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12496 · Cited by 15
“Population- level data have also suggested that elevated PTH may predispose people to increased CV risk (Hagstrom et al., 2009; Sugimoto et al., 2014; van Ballegooijen et al., 2013; Bansal et al., 2014), and may also be associated with risk for sudden cardiac death (Deo et al., 2011).”
BackgroundResultAngiotensin-Converting Enzyme Inhibition and Parathyroid Hormone Secretion
Zaheer, S., Brown, J. M., Connors, M., Williams, J. S., Adler, G. K., & Vaidya, A. (2017) · International Journal of Endocrinology · doi:10.1155/2017/4138783 · Cited by 12
Fibroblast growth factor 23 levels decline following sleeve gastrectomy
Billington, E. O., Murphy, R., Gamble, G. D., Callon, K. E., Davies, N., Plank, L. D., Booth, M., & Reid, I. R. (2019) · Clinical Endocrinology · doi:10.1111/cen.13981 · Cited by 12
Katô, H., Ito, N., Makita, N., Nangaku, M., Leung, A. M., & Inoue, K. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.09.005 · Cited by 11
Renal biomarkers for the prediction of cardiovascular disease
Joshi, S., & Viljoen, A. (2015) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000177 · Cited by 11
“Equally, there are prospective studies and a meta-analysis, which report that PTH is associated with all-cause and cardiovascular mortality [66,67].”
BackgroundCai, P., Tang, X., Qin, W., Ji, L., & Li, Z. (2016) · International Urology and Nephrology · doi:10.1007/s11255-015-1195-6 · Cited by 11
Risch, M., Risch, L., Purde, M.-T., Renz, H. E., Ambühl, P. M., Szucs, T. D., & Tomonaga, Y. (2016) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2016.1183262 · Cited by 11
Bone health among patients with primary aldosteronism: a systematic review and meta-analysis
Loh, H. H., Yee, A. H. A., & Loh, H. S. (2020) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02867-5 · Cited by 12
Korada, S. K. C., Zhao, D., Gottesman, R. F., Güallar, E., Lutsey, P. L., Alonso, Á., Sharrett, A. R., Post, W. S., Reis, J. P., Mosley, T. H., et al. (2016) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2015.12.029 · Cited by 12
Solesio, M. E., Mitaishvili, E., & Lymperopoulos, A. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.497 · Cited by 10
Lee, Y. H., Kweon, S., Choi, J., Nam, H., Park, K.-S., Choi, S.-W., Ryu, S. Y., Oh, S., & Shin, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186421 · Cited by 12
Prognostic Value of Serum Parathyroid Hormone Level in Acute Decompensated Heart Failure
Sugimoto, T., Dohi, K., Onishi, K., Yamada, T., Horiguchi, M., Takamura, T., Kawamura, A., Seko, T., Nakamura, M., Kasai, A., et al. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0481 · Cited by 9
Serum Parathyroid Hormone as a Potential Novel Biomarker of Coronary Heart Disease
Zhao, F., Zhang, Y.-Z., Tai, G.-X., Wang, Y., Tong, Q.-H., & Fu, L. (2014) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2014.0074 · Cited by 7
“…and the kidney, which are of great importance in maintaining calcium homeostasis, PTH receptors were also shown to be expressed in the myocardium and the vessel walls, suggesting that it may also directly affect the cardiovascular system (Schierbeck et al. , 2011; van Ballegooijen et al. , 2013a).”
Chen, W. R., Sha, Y., Chen, Y. D., Shi, Y., Yin, D. W., & Wang, H. (2014) · Endocrine Practice · doi:10.4158/ep13329.or · Cited by 7
Taiwan mini-frontier of primary aldosteronism: Updating treatment and comorbidities detection
Chan, C., Chang, Y., Tsai, Y., Chen, Z., Wu, C.-Y., Huang, W., Yen, I., Wu, K.-H., Wu, V., Lin, Y., et al. (2021) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2021.03.032 · Cited by 6
Zhang, W., Wang, Y., Wei, Z. C., Chang, G., Luo, Q., Abudusailamu, N., Nurula, M., Tao, S., Li, H., & Chen, Y. (2019) · Springer eBooks · doi:10.1007/978-981-15-0591-1_9 · Cited by 5
Serum level vitamin D and parathyroid hormone, and mortality, with or without chronic kidney disease
Choi, C. K., Kweon, S., Lee, Y. H., Nam, H., Park, K.-S., Ryu, S. Y., Choi, S.-W., Kim, S. A., & Shin, M. (2018) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-018-0979-z · Cited by 5
Cinamon, U., Gavish, D., Tamir, S. O., Goldfarb, A. R., & Ezri, T. (2017) · Head & Neck · doi:10.1002/hed.25002 · Cited by 5
Fernandes-Lima, F., Gregório, B. M., Nascimento, F. A. M., Costa, W. S., GALLO, C. B. M., & Sampaio, F. J. B. (2018) · BioMed Research International · doi:10.1155/2018/6030646 · Cited by 6
Parathyroidectomy and Cardiometabolic Risks in Patients With Primary Hyperparathyroidism
Tsur, N., Edri, N., Kerman, T., Talmor‐Barkan, Y., Kushnir, S., & Bachar, G. Y. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.44623 · Cited by 4
Vitamin D and Stroke: A Comparative Study to Risk Factors and Stroke Type
Tony, A. A. (2017) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v5i3.18 · Cited by 4
Cardiovascular disorders in patients with primary hyperparathyroidism according to registry data
Dobreva, E. A., Константиновна, Е. А., Mirnaya, S. S., Сергеевна, М. И., Айнетдинова, А. Р., Kryukova, I. V., Chagay, N. B., Маркина, Н. В., Podprugina, N. G., Mel'nichenko, G. A., et al. (2020) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20202306226 · Cited by 4
Kim, S. H., Kim, T. H., & Kim, S. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej14-0287 · Cited by 3
“high cardiovascular morbidity and mortality [13-15].”
Blast from the Past-using PTH to Differentiate Acute versus Chronic Kidney Disease
Kar, C. C. S. M. (2014) · Journal of Nephrology & Therapeutics · doi:10.4172/2161-0959.1000191 · Cited by 3
“These manifestations include increased risk for cardiovascular disease, decreased immune function, and an overall decreased quality of life [15,16].”
BackgroundAldosterone and Parathyroid Hormone: Evidence for a Clinically Relevant Relationship
Naik, V. (2019) · Journal of Endocrinology and Thyroid Research · doi:10.19080/jetr.2019.04.555637 · Cited by 3
Classic endocrine disorders: implications for cardiovascular disease
Krentz, A. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99991-5.00014-0 · Cited by 3
Primary hyperparathyroidism and cardiovascular risk. Is there a connection?
Delistathi, T., Markogiannakis, H., Tsamis, D., Manouras, A., Giotakis, I., & ZOGRAFOS, G. C. (2015) · Nova Journal of Medical and Biological Sciences · doi:10.20286/nova-jmbs-040263 · Cited by 1
Relationship Between Parathormone and Obesity-Linked Disorders
Temizkan, Ş., Demir, Ş., Aydın, K., Özderya, A., Öztürk, H. T., & Sargın, M. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0062
Cinacalcet does not provide cardiovascular protection in hemodialyzed patients
Martin, P. (2013) · IBMS BoneKEy · doi:10.1038/bonekey.2013.97
“In addition to the consequences observed on bone, it has been demonstrated that these abnormalities were associated with vascular calcification and an increased risk of cardiovascular (CV) mortality.(1) For these reasons, such abnormalities are considered as a systemic disorder called CKD–MBD for mineral and Bone Diso…”
BackgroundRossi, G. P., Seccia, T. M., & Accademico, A. (2014)
Vitamin D Status and Spontaneous Intra Cerebral Hemorrhage: Would it be Able to Help?
Tony, A. A., & KHOLEF, M. D. W. S. M. E. F. (2018) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2018.61857
The role of Vitamin D and Parathyroid Hormone in Cardiovascular Health
van Ballegooijen, A. J. (2014) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
Chronic inflammation in hemodialysis patients with secondary hyperparathyroidism
Dudar, І., Loboda, O., Dudar, S. L., & Savchuk, V. (2022) · Ukrainian Journal of Nephrology and Dialysis · doi:10.31450/ukrjnd.2(74).2022.08
“Вищі концентрації ПТГ асоціюються з підвищеним ризиком смертності серед літніх людей в загальній популяції [24, 25].”
Primary Hyperparathyroidism and Increased Cardiovascular Risk—A Review Article
Farooqui, K. J., Haider, F., Alfar, H., Baroudi, M. M., ferih, D. K., Farooqui, F. K., & Elsouki, A. N. (2023) · World Journal of Research and Review · doi:10.31871/wjrr.16.2.3
Uzunel, E., Lundin, H. R., Kronhed, A.-C. G., Wändell, P. E., & Salminen, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-80527-7
Öztürk, H., Öztürk, E. Ç., Yasun, Ö., Arat, E. K., Arat, O., Şahin, S. İ., Aydın, B. Ç., & Ataoğlu, H. E. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15062272
Cheng, X.-C., Mu, L.-Y., Wang, Z., Li, H., Qu, X.-Q., Liu, D., Li, S., Peng, B.-Q., Qiu, P., Jiang, Z.-Y., et al. (2026) · Calcified Tissue International · doi:10.1007/s00223-026-01604-9
Metadata
- Authors
- van Ballegooijen, A. J., Reinders, I., Visser, M., Dekker, J. M., Nijpels, G., Stehouwer, C. D. A., Pilz, S., & Brouwer, I. A.
- Affiliations
- Department of Health Sciences and the EMGO+ Institute for Health and Care Research (A.J.v.B., I.R., M.V., I.A.B.), 1081 HV Amsterdam, The Netherlands
- Amsterdam Public Health (NL)
- Maastricht University Medical Centre (NL)
- Medical University of Graz (AT)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-04-01
- Volume
- 98
- Issue
- 4
- Pages
- E638-E645
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2004959986
- Cited by
- 62
- References
- 40
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 4 · 2019: 6 · 2018: 3 · 2017: 5 · 2016: 6 · 2015: 11 · 2014: 13 · 2013: 4
- FWCI
- 8.58
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- VU Research Portal (publishedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- parathyroid hormone, all-cause mortality, cardiovascular mortality, hyperparathyroidism, renal function, older adults, Hoorn Study
- MeSH terms
- Aged, Aged, 80 and over, Cardiovascular Diseases, Cause of Death, Female, Humans, Male, Middle Aged, Netherlands, Osmolar Concentration, Parathyroid Hormone, Population, Cohort Studies, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.